1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Therapy

What Are the Most Profitable Therapies? Market Trends & Strategies Explained

  • Currently 2/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
16 votes

Global Therapy Industry 

The global therapy industry (one large revenue center of the pharma industry) involves treatments intended to protect from, cure or manage specific illnesses. The treatment of each therapeutic area and its specific conditions varies widely.

Therapy is usually decided on once the patient has been diagnosed with a specific medical condition or disease, though therapies may also be preventive measures. Therapies applied following diagnosis are either abortive or supportive. The former is a curative measure that seeks to inhibit development of the condition, while the latter relieves the patient’s suffering due to the symptoms of the disease without treating the condition itself.

Preventive therapies are used to safeguard people against disease; for example, vaccinations are used to prevent infections such as polio, smallpox and measles.

Market Trends

The combined market for medicines and therapies (such as oncology) used in the treatment of disease is witnessing a slower rate of spending: in the five years up to 2010, spending on medicines grew by more than 6% yearly. However, in the five years up to 2015, the rate of growth is slowing to between 3% and 6%. Global spending on medicine and therapy in 2015 is forecast to reach $1.1 trillion, reports the IMS Institute for Healthcare and Informatics.

The market is to see increased spending on generic drugs, hitting almost 40% growth in 2015 or nearly doubling in a decade. Spending on brand-name medicines should drop by $120 billion in the five-year period ending in 2015.

Increased prevalence of type 2 diabetes, particularly in emerging markets such as China, Brazil and India, will see global spending on the disease rise 4%-7% through 2015, with oral antidiabetics increasingly favored. Spending on therapeutic medicine to treat asthma and chronic obstructive lung disease will drop from 9% in the five-year period ending in 2010 to 2%-5% from 2010 to 2015.

Therapy Spending Forecasts to 2015 *In US$ Billion 

Key Market Segments

According to a report by the IMS Institute for Healthcare Informatics, oncology will continue to hold the top spot in the therapies industry, with forecast revenue between $75 billion and $80 billion in 2015, representing a jump of more than $20 billion in a five-year period. Lipid regulators will fall from second to fourth place, reaching between $29 billion and $34 billion in the same period. Meanwhile, anti-diabetics will rise to second place at between $43 billion and $48 billion.

Respiratory agents are expected to remain the third-biggest seller, with a $5 billion to $10 billion increase on 2010 sales. Drugs to treat hypertension are forecast to rise to fifth place with an up to $6.5 billion increase in revenue. Overall, auto-immune drugs should see a substantial jump to reach between $27 billion and $32 billion by 2015.

HIV antivirals are expected to jump from tenth to seventh place with sales of between $20 billion and $24 billion by 2015. A substantial drop in market share is expected for antidepressants, from more than $20 billion in 2010 to between $13 billion and $16 billion in 2015.  Treatments for multiple sclerosis should rise several places in the same period, marking revenue from under $10 billion to between $12 billion and $15 billion. Antipsychotics are forecast to see a $5 billion drop to $20 billion in 2015.

Therapy segments expected to drop out of the top-20 list include vitamins and minerals, antirheumatics, cephalosporins, combs (antibiotics) and vaccines. Categories expected to appear in the top 20 include treatments for glaucoma, Alzheimer’s, osteoporosis and attention deficit hyperactivity disorder.

Categories expected to show less substantial fluctuation include narcotic analgesics, antiepileptics and erythropoietics.

Top 20 Global Therapeutic Categories (2015) 

Read more »

You might be interested in these related markets:

Customer Support

Talk to Sam

+44 208 068 8943

1200 Reports
Supply, Demand, Company
570 Statistics
Market Size, Demand, Company
8800 Reports
Company Financials, Demand, Company
1300 Statistics
Market Size, Finance, Company Financials
410 Reports
Demand, Supply, Company Financials
160 Statistics
Market Size, Demand, Finance
290 Reports
Demand, Supply, Company Financials
190 Statistics
Market Size, Finance, Company Financials
1100 Reports
Demographic, Social Conditions, Supply
760 Statistics
Demographic, Environment, Social Conditions
310 Reports
Supply, Demand, Company Financials
370 Statistics
Market Size, Demand, Finance
460 Reports
Demographic, Supply, Demand
140 Statistics
Demographic, Environment, Social Conditions
740 Reports
Demographic, Company, Social Conditions
120 Statistics
Environment, Social Conditions, Market Size
42 Reports
Supply, Demand, Demographic
73 Statistics
Market Size, Demand, Demographic
94 Reports
Demand, Demographic, Social Conditions
74 Statistics
Market Size, Demand, Finance
Search in Therapy Industry (About 31000 reports)
Parent industry: Pharmaceutical
Related industries: Drug Delivery, Drug Development, Generic Drug, OTC, Prescription Drug, Biopharmaceutical

About 12000 reports

Purchase Reports From Reputable Market Research Publishers

2019-2023 Global Immunodiagnostic Analyzers and Reagents Market: Emerging Opportunities in Americas, EMEA, APAC--A 75-Country Survey--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

2019-2023 Global Immunodiagnostic Analyzers and Reagents Market: Emerging Opportunities in Americas, EMEA, APAC--A 75-Country Survey--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • € 65775
  • Industry report
  • January 2019

2019-2023 Global Immunodiagnostic Analyzers and Reagents Market: Emerging Opportunities in Americas, EMEA, APAC--A 75-Country Survey--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, ...

2019-2023 World Clinical Chemistry Analyzers and Reagen ... € 65775 January 2019

2018 World Clinical Chemistry Analyzers and Reagents Ma ... € 65775 March 2018

2019-2023 Europe Immunodiagnostic Analyzers and Reagent ... € 32888 January 2019

2019-2023 Europe Clinical Chemistry Analyzers and Reage ... € 32888 January 2019

2019-2023 Global Clinical Chemistry and Immunodiagnosti ... € 20610 January 2019

2018 Global Clinical Chemistry and Immunodiagnostics Ma ... € 20610 June 2018

2018 Clinical Chemistry and Immunodiagnostic Analyzers ... € 20610 June 2018

2018 World Immunodiagnostics Market € 20610 April 2018

Bipolar Disorder Disease Coverage to 2024 € 19294 April 2018


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on